| Patents for C40B 30 - Methods of screening libraries (11,320) |
|---|
| 02/09/2012 | US20120035062 Alternative nucleotide flows in sequencing-by-synthesis methods |
| 02/09/2012 | US20120035061 Optical imaging based on viscoelastic focusing |
| 02/09/2012 | US20120034317 Prediction of Response to Platinum-Based Therapy |
| 02/09/2012 | US20120034236 Co-targeting of aurora a kinase and lim kinase 1 for cancer therapy |
| 02/09/2012 | US20120034235 Marker for Liver-Cancer Diagnosis and Recurrence and Survival Prediction, a Kit Comprising the Same, and Prognosis Prediction in Liver-Cancer Patients Using the Marker |
| 02/09/2012 | US20120034226 Diagnostic method of skin inflammatory disease |
| 02/09/2012 | US20120034218 RBM3 in Colorectal Cancer Prognostics |
| 02/09/2012 | US20120034214 Methods and kits for determining the prognosis of pulmonary sarcoidosis |
| 02/09/2012 | US20120034192 Compositions and methods for enhancing cell reprogramming |
| 02/09/2012 | US20120034166 Amyloid beta(1-42) oligomers, derivatives thereof and antibodies thereto, methods of preparation thereof and use thereof |
| 02/07/2012 | CA2645194C Isolation of binding proteins with high affinity to ligands |
| 02/02/2012 | WO2012015249A2 Method for screening diabetes treating agent |
| 02/02/2012 | WO2001080622A3 Apparatus and methods for assays of one or more analytes |
| 02/02/2012 | US20120030839 Expression and High-Throughput Screening of Complex Expressed DNA Libraries in Filamentous Fungi |
| 02/02/2012 | US20120030776 Novel gene disruptions, compositions and methods relating thereto |
| 02/02/2012 | US20120029056 Differentially expressed micrornas as biomarkers for the diagnosis and treatment of sjögren's syndrome |
| 02/02/2012 | US20120028907 Methods for identification of tumor phenotype and treatment |
| 02/02/2012 | US20120028901 Tfpi inhibitors and methods of use |
| 02/02/2012 | US20120028881 Methods and reagents for diagnosing atheroma |
| 02/02/2012 | US20120028838 Quantification of Gene Expression |
| 02/02/2012 | US20120028837 Rapid screen for reproductive toxicants |
| 02/02/2012 | US20120028836 Use of protein satb2 as a marker for colorectal cancer |
| 02/02/2012 | US20120028835 Secernin-1 as a marker for cancer |
| 02/02/2012 | US20120028834 Color encoded magnetic structure |
| 02/02/2012 | US20120028833 MiR-25-BASED METHODS FOR THE DIAGNOSIS AND PROGNOSIS OF ACUTE MYELOID LEUKEMIA (AML) |
| 02/02/2012 | US20120028832 MiR-182-, miR-191, miR-199a-BASED METHODS FOR THE DIAGNOSIS AND PROGNOSIS OF ACUTE MYELOID LEUKEMIA (AML) |
| 02/02/2012 | US20120028831 MiR-29-BASED METHODS FOR THE DIAGNOSIS AND PROGNOSIS OF ACUTE MYELOID LEUKEMIA (AML) |
| 02/02/2012 | US20120028830 Microfluidic device for simultaneously conducting multiple analyses |
| 02/02/2012 | US20120028829 Anti-hedgehog antibodies |
| 02/02/2012 | US20120028828 Fluorescent Methods and Materials for Directed Biomarker Signal Amplification |
| 02/02/2012 | US20120028827 Method for determining a risk, for a subject, of suffering from atopic dermatitis or severity of atopic dermatitis for a subject suffering from atopic dermatitis and method for using a single-nucleotide polymorphism rs12313273 as a biomarker for determining the development or severity of atopic dermatitis |
| 02/02/2012 | US20120028826 Methods and Compositions for Analysis of Nucleic Acids |
| 02/02/2012 | US20120028825 Galectin-1 (gal1) as a biomarker for differential diagnosis of osteosarcoma and chondrosarcoma |
| 02/02/2012 | US20120028824 Method for the in vitro diagnosis of stroke |
| 02/02/2012 | US20120028823 pH MODULATION METHOD TO DETECT LIGAND-RECEPTOR BINDING |
| 02/02/2012 | US20120028822 Methods, flow cells and systems for single cell analysis |
| 02/02/2012 | US20120028821 Programming and reprogramming of cells |
| 02/02/2012 | US20120028820 Hybrid sensor array |
| 02/02/2012 | US20120028819 Method for the detection and characterization of a toxinogenic clostridium difficile strain |
| 02/02/2012 | US20120028818 Micro fluidic structures |
| 02/02/2012 | US20120028817 Methods and Kits for Genome-Wide Methylation of GpC Sites and Genome-Wide Determination of Chromatin Structure |
| 02/02/2012 | US20120027766 Methods and means for treatment of osteoarthritis |
| 02/02/2012 | US20120027749 Method |
| 02/02/2012 | CA2804626A1 Method for using gene expression to determine prognosis of prostate cancer |
| 02/01/2012 | EP1737972B1 Protein-protein interactions for pharmacological profiling |
| 01/31/2012 | US8105983 High-throughput method for optimum solubility screening for homogeneity and crystallization of proteins |
| 01/31/2012 | US8105982 Aptamers and methods for their in vitro selection and uses thereof |
| 01/31/2012 | US8105845 System and method for carrying out multiple binding reactions in an array format |
| 01/26/2012 | WO2012012802A2 Neoepitope detection of disease using protein arrays |
| 01/26/2012 | WO2012012725A2 Methods of detecting diseases or conditions using phagocytic cells |
| 01/26/2012 | WO2012012703A2 Identification of differentially represented fetal or maternal genomic regions and uses thereof |
| 01/26/2012 | WO2012012693A2 Methods for detecting signatures of disease or conditions in bodily fluids |
| 01/26/2012 | WO2012012278A2 Compositions and methods for the treatment of pathological condition(s) related to gpr35 and/or gpr35-herg complex |
| 01/26/2012 | WO2012009813A1 Methods of detecting genetic polymorphisms using melting temperature of probe-amplicon complexes |
| 01/26/2012 | WO2011109726A3 Homologous multi-specific antibodies |
| 01/26/2012 | US20120022128 PKIB and NAALADL2 for Target Genes of Prostate Cancer Therapy and Diagnosis |
| 01/26/2012 | US20120022116 Compositions and methods for the treatment of pathological condition(s) related to gpr35 and/or gpr35-herg complex |
| 01/26/2012 | US20120021993 Protein scaffold library based on kringle domain structure and uses thereof |
| 01/26/2012 | US20120021983 Compositions and methods for diagnosis and prognosis of cancer and progression, and for screening anti-cancer agents |
| 01/26/2012 | US20120021967 Synthetic antibodies |
| 01/26/2012 | US20120021950 Expression Vector |
| 01/26/2012 | US20120021949 Methylation Ligation-Dependent Macroarray (MLM) |
| 01/26/2012 | US20120021948 Surface display of whole antibodies in eukaryotes |
| 01/26/2012 | US20120021947 System and Method to Obtain Oligo-Peptides with Specific High Affinity to Query Proteins |
| 01/26/2012 | US20120021946 Method of diagnosing esophageal cancer |
| 01/26/2012 | US20120021945 Hypoxia-Inducible Protein 2 (HIG2), a Diagnostic Marker for Clear Cell Renal Cell Carcinoma |
| 01/26/2012 | US20120021944 Co-Coupling To Control Reactivity Of Reagents In Immunoassays |
| 01/26/2012 | US20120021943 Multiple genetic disease diagnostic panels by one single test using microarray technology |
| 01/26/2012 | US20120021942 Use of fccs for the analysis of interaction parameters in an in vivo-like environment |
| 01/26/2012 | US20120021941 Blood test for the detection of cancer |
| 01/26/2012 | US20120021940 Compositions, Methods, and Kits for Identifying Candidate Molecules from Encoded Chemical Libraries |
| 01/26/2012 | US20120021939 Method for profiling drug compounds using protein kinase inhibitors |
| 01/26/2012 | US20120021938 Method for detecting transcription factor-protein interactions |
| 01/26/2012 | US20120021937 Detection of carcinoma in situ in semen specimens |
| 01/26/2012 | US20120021936 Biomarkers for dengue |
| 01/26/2012 | US20120021935 Signature for the diagnosis of cancer aggressiveness and genetic instability |
| 01/26/2012 | US20120021934 Methods and Devices for Active Bioassay |
| 01/26/2012 | US20120021933 Small molecule printing |
| 01/26/2012 | US20120021932 Multiplexed Olfactory Receptor-Based Microsurface Plasmon Polariton Detector |
| 01/26/2012 | US20120021931 Devices and methods for batch processing magnetic bead assays |
| 01/26/2012 | US20120021930 Multiplex Nucleic Acid Detection |
| 01/26/2012 | US20120021929 Use of dppiv/seprase as a marker for cancer |
| 01/26/2012 | US20120021928 Genetic risk assessment for shar-pei fever |
| 01/26/2012 | US20120021927 Methods for Determining a Prognosis for Survival for a Patient with Breast Cancer |
| 01/26/2012 | US20120021926 Fluorescence resonance energy transfer assays for sarco/endoplasmic reticulum calcium atpase and phospholamban |
| 01/26/2012 | US20120021925 Diagnostic assays for prostate cancer using psp94 and psa biomarkers |
| 01/26/2012 | US20120021924 Detection and modulation of cytochrome c acetylation |
| 01/26/2012 | US20120021923 Methods and systems to diagnose a condition in an individual |
| 01/26/2012 | US20120021922 Translation-coupling systems |
| 01/26/2012 | US20120021921 Process and method for monitoring gastrointestinal microbiota |
| 01/26/2012 | US20120021920 Radiation therapy biomarkers |
| 01/26/2012 | US20120021919 Identification of Differentially Represented Fetal or Maternal Genomic Regions and Uses Thereof |
| 01/26/2012 | US20120020970 Methods of evaluating patients |
| 01/26/2012 | US20120020959 Use of the sparc microenvironment signature in the treatment of cancer |
| 01/26/2012 | US20120020957 Dengue virus neutralizing antibodies and use thereof |
| 01/26/2012 | US20120020955 Detection of Neurological Disorders With Immune Reactions |
| 01/26/2012 | US20120020954 Methods of predicting clinical course and treating multiple sclerosis |
| 01/26/2012 | US20120020953 Diagnosis and treatment of cancer |
| 01/26/2012 | US20120020929 Methods and compositions relating to neuronal cell and tissue differentiation |
| 01/26/2012 | US20120020889 Polypeptides Targeting Vascular Endothelial Growth Factor Receptor-2 and Alpha V Beta 3 Integrin |